PMC:7102662 / 6290-10949
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T14 | 73-76 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T15 | 334-351 | Body_part | denotes | respiratory tract | http://purl.org/sig/ont/fma/fma265130 |
T16 | 390-399 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T17 | 585-590 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T18 | 706-711 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T19 | 716-721 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T20 | 782-791 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T21 | 970-974 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T22 | 1108-1116 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T23 | 1263-1272 | Body_part | denotes | cytokines | http://purl.org/sig/ont/fma/fma84050 |
T24 | 1714-1719 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T25 | 2051-2060 | Body_part | denotes | CV system | http://purl.org/sig/ont/fma/fma7161 |
T26 | 4318-4323 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T8 | 334-351 | Body_part | denotes | respiratory tract | http://purl.obolibrary.org/obo/UBERON_0000065 |
T9 | 706-711 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T10 | 970-974 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T11 | 1163-1169 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
T12 | 1714-1719 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T13 | 4318-4323 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T61 | 31-39 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T62 | 162-172 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T63 | 287-291 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T64 | 314-322 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T65 | 378-386 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T66 | 516-524 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T67 | 553-559 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T68 | 561-569 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T69 | 866-874 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T70 | 975-981 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T71 | 1002-1014 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T72 | 1037-1045 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T73 | 1144-1150 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T74 | 1181-1199 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T75 | 1306-1314 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T76 | 1428-1437 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T77 | 1580-1586 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
T78 | 1611-1630 | Disease | denotes | coronary thrombosis | http://purl.obolibrary.org/obo/MONDO_0006716 |
T79 | 1620-1630 | Disease | denotes | thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T80 | 1641-1653 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T81 | 1769-1796 | Disease | denotes | acute myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0004781 |
T82 | 1775-1796 | Disease | denotes | myocardial infarction | http://purl.obolibrary.org/obo/MONDO_0005068 |
T83 | 1839-1851 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T84 | 2001-2009 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T85 | 2172-2183 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T86 | 2270-2281 | Disease | denotes | hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T87 | 2285-2293 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T88 | 2317-2325 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T89 | 2375-2386 | Disease | denotes | Hypokalemia | http://purl.obolibrary.org/obo/MONDO_0003019 |
T90 | 2569-2577 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T91 | 2797-2806 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T92 | 2889-2897 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T93 | 2943-2951 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T94 | 2960-2983 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T95 | 2988-3000 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T96 | 3046-3054 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T97 | 3059-3071 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T98 | 3159-3182 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T99 | 3242-3250 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T100 | 3259-3282 | Disease | denotes | cerebrovascular disease | http://purl.obolibrary.org/obo/MONDO_0011057 |
T101 | 3287-3299 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T102 | 3618-3626 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T103 | 3775-3787 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T104 | 3789-3797 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T105 | 4277-4285 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T106 | 4307-4331 | Disease | denotes | congestive heart failure | http://purl.obolibrary.org/obo/MONDO_0005009 |
T107 | 4318-4331 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T36 | 55-56 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T37 | 156-161 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T38 | 390-399 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T39 | 579-590 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cells |
T40 | 645-646 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T41 | 647-655 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T42 | 706-711 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T43 | 706-711 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T44 | 706-711 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T45 | 706-711 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T46 | 716-721 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T47 | 782-791 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T48 | 918-927 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T49 | 970-974 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T50 | 970-974 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T51 | 1163-1169 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T52 | 1714-1719 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T53 | 1714-1719 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T54 | 2051-2060 | http://purl.obolibrary.org/obo/UBERON_0004535 | denotes | CV system |
T55 | 2808-2809 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T56 | 3320-3323 | http://purl.obolibrary.org/obo/CLO_0001562 | denotes | a 2 |
T57 | 3320-3323 | http://purl.obolibrary.org/obo/CLO_0001563 | denotes | a 2 |
T58 | 3482-3483 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T59 | 4103-4108 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2]. A |
T60 | 4196-4197 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T61 | 4318-4323 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T62 | 4318-4323 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T63 | 4318-4323 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T64 | 4318-4323 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T5 | 77-81 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T6 | 118-122 | Chemical | denotes | beta | http://purl.obolibrary.org/obo/CHEBI_10545 |
T7 | 605-616 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T8 | 1517-1523 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T9 | 1930-1945 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 1930-1939 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 1940-1945 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 1947-1962 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
T13 | 2339-2350 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T14 | 2351-2362 | Chemical | denotes | aldosterone | http://purl.obolibrary.org/obo/CHEBI_27584|http://purl.obolibrary.org/obo/CHEBI_30834 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T20 | 1108-1122 | Phenotype | denotes | cytokine storm | http://purl.obolibrary.org/obo/HP_0033041 |
T21 | 1451-1458 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
T22 | 1475-1494 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
T23 | 1775-1796 | Phenotype | denotes | myocardial infarction | http://purl.obolibrary.org/obo/HP_0001658 |
T24 | 2172-2183 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T25 | 2270-2281 | Phenotype | denotes | hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T26 | 2375-2386 | Phenotype | denotes | Hypokalemia | http://purl.obolibrary.org/obo/HP_0002900 |
T27 | 2988-3000 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T28 | 3059-3071 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T29 | 3287-3299 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T30 | 3775-3787 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T31 | 4307-4331 | Phenotype | denotes | congestive heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 768-778 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
T11 | 918-936 | http://purl.obolibrary.org/obo/GO_0007165 | denotes | signaling pathways |
T12 | 918-927 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
T13 | 1002-1014 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T14 | 1082-1103 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory response |
T15 | 1641-1653 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T16 | 1839-1851 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T56 | 0-30 | Sentence | denotes | 2.1 Pathogenic considerations |
T57 | 31-94 | Sentence | denotes | SARS-CoV-2 is caused by a novel enveloped RNA beta-coronavirus. |
T58 | 95-324 | Sentence | denotes | Seven species of these beta-coronaviruses are known to cause human infections, with four mainly causing mild flulike symptoms and the remaining three resulting in potentially fatal illnesses (SARS, MERS and the ongoing COVID-19). |
T59 | 325-443 | Sentence | denotes | Although respiratory tract is the primary target for SARS-CoV-2, CV system may get involved in several different ways. |
T60 | 444-533 | Sentence | denotes | Following are the common mechanisms responsible for CV complications in COVID-19 [3,4]-1. |
T61 | 535-722 | Sentence | denotes | Direct myocardial injury- SARS-CoV-2 enters human cells by binding to angiotensin-converting enzyme 2 (ACE2), a membrane bound aminopeptidase which is highly expressed in heart and lungs. |
T62 | 723-850 | Sentence | denotes | ACE2 plays an important role in neurohumoral regulation of CV system in normal health as well as in various disease conditions. |
T63 | 851-988 | Sentence | denotes | The binding of SARS-CoV-2 to ACE2 can result in alteration of ACE2 signaling pathways, leading to acute myocardial and lung injury [3,4]. |
T64 | 989-991 | Sentence | denotes | 2. |
T65 | 993-1200 | Sentence | denotes | Systemic inflammation- More severe forms of COVID-19 are characterized by acute systemic inflammatory response and cytokine storm, which can result in injury to multiple organs leading to multiorgan failure. |
T66 | 1201-1321 | Sentence | denotes | Studies have shown high circulatory levels of proinflammatory cytokines in patients with severe/critical COVID-19 [5,6]. |
T67 | 1322-1324 | Sentence | denotes | 3. |
T68 | 1326-1587 | Sentence | denotes | Altered myocardial demand-supply ratio- Increased cardiometabolic demand associated with the systemic infection coupled with hypoxia caused by acute respiratory illness can impair myocardial oxygen demand-supply relationship and lead to acute myocardial injury. |
T69 | 1588-1590 | Sentence | denotes | 4. |
T70 | 1592-1797 | Sentence | denotes | Plaque rupture and coronary thrombosis- Systemic inflammation as well as increased shear stress due to increased coronary blood flow can precipitate plaque rupture resulting in acute myocardial infarction. |
T71 | 1798-1879 | Sentence | denotes | Prothrombotic milieu created by systemic inflammation further increases the risk. |
T72 | 1880-1882 | Sentence | denotes | 5. |
T73 | 1884-2061 | Sentence | denotes | Adverse effects of various therapies- Various antiviral drugs, corticosteroids and other therapies aimed at treating COVID-19 can also have deleterious effects on the CV system. |
T74 | 2062-2064 | Sentence | denotes | 6. |
T75 | 2066-2235 | Sentence | denotes | Electrolyte imbalances- Electrolyte imbalances can occur in any critical systemic illness and precipitate arrhythmias, esp. in patients with underlying cardiac disorder. |
T76 | 2236-2374 | Sentence | denotes | There is particular concern about hypokalemia in COVID-19, due to interaction of SARS-CoV-2 with renin-angiotensin-aldosterone system [7]. |
T77 | 2375-2439 | Sentence | denotes | Hypokalemia increases vulnerability to various tachyarrhythmias. |
T78 | 2441-2482 | Sentence | denotes | 2.1.1 Role of underling CV comorbidities |
T79 | 2483-2654 | Sentence | denotes | The patients with pre-existing CVD appear to have heightened vulnerability to develop COVID-19 and tend to have more severe disease with worse clinical outcomes [1,4,6,8]. |
T80 | 2655-2807 | Sentence | denotes | Various CV risk factors also adversely affect porgnosis of these patients, although they do not seem to increase likleihood of developing the infection. |
T81 | 2808-3018 | Sentence | denotes | A meta-analysis of six published studies from China including 1527 patients with COVID-19 reported 9.7%, 16.4% and 17.1% prevalence of diabetes, cardio-cerebrovascular disease and hypertension respectively [4]. |
T82 | 3019-3207 | Sentence | denotes | Although the prevalence of diabetes and hypertension in this cohort was same as in the Chinese general population, the prevalence of cardio-cerebrovascular disease was considerably higher. |
T83 | 3208-3481 | Sentence | denotes | More importantly, the presence of diabetes, cardio-cerebrovascular disease and hypertension was associated with a 2-fold, 3-fold and 2-fold greater risk of severe disease or requiring intensive care unit (ICU) admission, suggesting prognostic impact of these comorbidities. |
T84 | 3482-3631 | Sentence | denotes | A much larger report from the Chinese Center for Disease Control and Prevention described clinical outcomes in 44672 confirmed cases of COVID-19 [1]. |
T85 | 3632-3806 | Sentence | denotes | The overall case fatality rate (CFR) was 2.3% in the entire cohort but significantly higher (6%, 7.3% and 10.5% respectively) in patients with hypertension, diabetes and CVD. |
T86 | 3807-3978 | Sentence | denotes | Although data is lacking, the prevalence of various CV comorbidities and their impact on clinical outcomes seem to vary considerably across different geographic locations. |
T87 | 3979-4106 | Sentence | denotes | The CFRs have been lower in China outside Hubei province and many other countries but much higher in some European nations [2]. |
T88 | 4107-4229 | Sentence | denotes | A small report including 21 patients from Washington, United States of America presented a particularly grim scenario [9]. |
T89 | 4230-4341 | Sentence | denotes | Comorbidities were common in this cohort, with diabetes present in 33.3% and congestive heart failure in 42.9%. |
T90 | 4342-4419 | Sentence | denotes | Acute cardiac dysfunction occurred in 33.3% patients and 52.4% patients died. |
T91 | 4420-4659 | Sentence | denotes | However, the overall CFR in the United States seems to be much lower (201 deaths out of 15219 confirmed cases) [2], although it is likely to rise as many of the patients are currently hospitalized and have not yet had the definite outcome. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 31-41 | SP_7 | denotes | SARS-CoV-2 |
T112 | 82-93 | NCBITaxon:11118 | denotes | coronavirus |
T113 | 101-108 | NCBITaxon:species | denotes | species |
T114 | 123-136 | NCBITaxon:11118 | denotes | coronaviruses |
T115 | 156-161 | SP_6;NCBITaxon:9606 | denotes | human |
T116 | 287-291 | SP_10 | denotes | SARS |
T117 | 293-297 | SP_9 | denotes | MERS |
T118 | 314-322 | SP_7 | denotes | COVID-19 |
T119 | 334-351 | UBERON:0000065 | denotes | respiratory tract |
T120 | 378-388 | SP_7 | denotes | SARS-CoV-2 |
T121 | 516-524 | SP_7 | denotes | COVID-19 |
T122 | 542-552 | UBERON:0002349 | denotes | myocardial |
T123 | 561-571 | SP_7 | denotes | SARS-CoV-2 |
T124 | 579-584 | SP_6;NCBITaxon:9606 | denotes | human |
T125 | 605-636 | PG_10;PR:000003622 | denotes | angiotensin-converting enzyme 2 |
T126 | 638-642 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T127 | 647-655 | GO:0016020 | denotes | membrane |
T128 | 693-702 | GO:0010467 | denotes | expressed |
T129 | 706-711 | UBERON:0000948 | denotes | heart |
T130 | 716-721 | UBERON:0000170 | denotes | lungs |
T131 | 723-727 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T132 | 768-778 | GO:0065007 | denotes | regulation |
T133 | 782-784 | UBERON:0001017 | denotes | CV |
T134 | 866-876 | SP_7 | denotes | SARS-CoV-2 |
T135 | 880-884 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T136 | 913-917 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
T137 | 955-965 | UBERON:0002349 | denotes | myocardial |
T138 | 970-974 | UBERON:0002048 | denotes | lung |
T177 | 1037-1045 | SP_7 | denotes | COVID-19 |
T178 | 1163-1169 | UBERON:0000062 | denotes | organs |
T179 | 1181-1191 | UBERON:0000062 | denotes | multiorgan |
T180 | 1306-1314 | SP_7 | denotes | COVID-19 |
T181 | 1334-1344 | UBERON:0002349 | denotes | myocardial |
T182 | 1475-1486 | UBERON:0001004 | denotes | respiratory |
T183 | 1506-1516 | UBERON:0002349 | denotes | myocardial |
T184 | 1569-1579 | UBERON:0002349 | denotes | myocardial |
T185 | 1611-1619 | UBERON:0005985 | denotes | coronary |
T186 | 1620-1630 | GO:0007596 | denotes | thrombosis |
T187 | 1705-1713 | UBERON:0005985 | denotes | coronary |
T188 | 1714-1719 | UBERON:0000178 | denotes | blood |
T189 | 1775-1785 | UBERON:0002349 | denotes | myocardial |
T190 | 1798-1811 | GO:0007596 | denotes | Prothrombotic |
T191 | 1940-1945 | CHEBI:36044;CHEBI:36044 | denotes | drugs |
T192 | 1947-1962 | CHEBI:50858;CHEBI:50858 | denotes | corticosteroids |
T193 | 2001-2009 | SP_7 | denotes | COVID-19 |
T194 | 2218-2225 | UBERON:0000948 | denotes | cardiac |
T195 | 2285-2293 | SP_7 | denotes | COVID-19 |
T196 | 2317-2327 | SP_7 | denotes | SARS-CoV-2 |
T197 | 2333-2338 | PR:000013883 | denotes | renin |
T198 | 2569-2577 | SP_7 | denotes | COVID-19 |
T199 | 2889-2897 | SP_7 | denotes | COVID-19 |
T200 | 2960-2975 | UBERON:0002037 | denotes | cerebrovascular |
T201 | 3159-3174 | UBERON:0002037 | denotes | cerebrovascular |
T202 | 3259-3274 | UBERON:0002037 | denotes | cerebrovascular |
T203 | 3402-3406 | CL:0000037 | denotes | care |
T204 | 3618-3626 | SP_7 | denotes | COVID-19 |
T205 | 4318-4323 | UBERON:0000948 | denotes | heart |
T206 | 4348-4355 | UBERON:0000948 | denotes | cardiac |
T207 | 4414-4418 | GO:0016265 | denotes | died |
T208 | 4494-4500 | GO:0016265 | denotes | deaths |
T90623 | 1533-1541 | SP_7 | denotes | pply rel |
T3419 | 1587-1595 | UBERON:0000948 | denotes | 4. Pla |
T78722 | 1843-1851 | SP_7 | denotes | ammation |
T53635 | 1856-1865 | GO:0007612 | denotes | her incre |
T94419 | 1885-1896 | NCBITaxon:11118 | denotes | dverse effe |
T38989 | 1915-1920 | SP_10 | denotes | apies |
T67414 | 1958-1962 | SP_9 | denotes | oids |
T60021 | 2192-2200 | SP_7 | denotes | patient |
T3699 | 2224-2232 | SP_7 | denotes | c disord |
T86101 | 2239-2250 | NCBITaxon:11118 | denotes | re is parti |
T88588 | 2283-2290 | UBERON:0000948 | denotes | n COVID |
T53986 | 2294-2308 | UBERON:0004535 | denotes | due to intera |
T35855 | 2326-2336 | UBERON:0002349 | denotes | 2 with ren |
T55568 | 2366-2371 | UBERON:0000948 | denotes | tem [ |
T45400 | 2435-2439 | SP_10 | denotes | ias. |
T96699 | 2445-2450 | SP_9 | denotes | 1 Ro |
T94696 | 2501-2512 | SP_7 | denotes | pre-existin |
T73378 | 2550-2561 | NCBITaxon:11118 | denotes | ability to |
T49479 | 2569-2576 | NCBITaxon:species | denotes | COVID-1 |
T49662 | 2588-2601 | NCBITaxon:11118 | denotes | o have more s |
T91764 | 2621-2626 | SP_6;NCBITaxon:9606 | denotes | orse |
T16144 | 2752-2756 | SP_10 | denotes | eem |
T61914 | 2758-2762 | SP_9 | denotes | inc |
T67143 | 2779-2787 | SP_7 | denotes | of devel |
T79419 | 2800-2818 | UBERON:0000065 | denotes | ection. A meta-ana |
T22287 | 2845-2857 | SP_7 | denotes | ies from Chi |
T48200 | 2985-2993 | SP_7 | denotes | nd hyper |
T78437 | 3010-3020 | UBERON:0002349 | denotes | ely [4]. A |
T61571 | 3029-3039 | SP_7 | denotes | he prevale |
T36103 | 3047-3052 | SP_6;NCBITaxon:9606 | denotes | iabet |
T42181 | 3073-3104 | PG_10;PR:000003622 | denotes | n this cohort was same as in th |
T13911 | 3106-3112 | G_3;PG_10;PR:000003622 | denotes | Chines |
T79903 | 3117-3125 | GO:0016020 | denotes | eral pop |
T50101 | 3163-3172 | GO:0010467 | denotes | brovascul |
T80107 | 3176-3181 | UBERON:0000948 | denotes | iseas |
T55772 | 3186-3191 | UBERON:0000170 | denotes | cons |
T53520 | 3193-3197 | G_3;PG_10;PR:000003622 | denotes | erab |
T48624 | 3238-3248 | GO:0065007 | denotes | of diabet |
T21124 | 3252-3254 | UBERON:0001017 | denotes | ca |
T78086 | 3336-3346 | SP_7 | denotes | and 2-fol |
T54232 | 3350-3354 | G_3;PG_10;PR:000003622 | denotes | eate |
T64983 | 3383-3387 | G_3;PG_10;PR:000003622 | denotes | equi |
T4317 | 3425-3435 | UBERON:0002349 | denotes | on, sugges |
T54741 | 3440-3444 | UBERON:0002048 | denotes | prog |
T139 | 3506-3516 | SP_7 | denotes | m the Chin |
T140 | 3633-3639 | UBERON:0000062 | denotes | he ove |
T141 | 3651-3660 | UBERON:0000062 | denotes | tality ra |
T142 | 3775-3783 | SP_7 | denotes | hyperten |
T143 | 3801-3811 | UBERON:0002349 | denotes | CVD. Alth |
T144 | 3939-3949 | UBERON:0001004 | denotes | across di |
T145 | 3971-3981 | UBERON:0002349 | denotes | ations. Th |
T146 | 4036-4046 | UBERON:0002349 | denotes | and many o |
T147 | 4077-4085 | UBERON:0005985 | denotes | in some |
T148 | 4086-4096 | GO:0007596 | denotes | uropean na |
T149 | 4171-4179 | UBERON:0005985 | denotes | tes of A |
T150 | 4180-4185 | UBERON:0000178 | denotes | erica |
T151 | 4240-4250 | UBERON:0002349 | denotes | ies were c |
T152 | 4263-4276 | GO:0007596 | denotes | cohort, with |
T153 | 4402-4407 | CHEBI:36044;CHEBI:36044 | denotes | 4% pa |
T154 | 4409-4424 | CHEBI:50858;CHEBI:50858 | denotes | ents died. Howe |
T155 | 4462-4470 | SP_7 | denotes | tes seem |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32247212-31986264-25241178 | 1318-1319 | 31986264 | denotes | 6 |
32247212-31986264-25241179 | 2649-2650 | 31986264 | denotes | 6 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
192 | 605-636 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
193 | 638-642 | Gene | denotes | ACE2 | Gene:59272 |
194 | 723-727 | Gene | denotes | ACE2 | Gene:59272 |
195 | 880-884 | Gene | denotes | ACE2 | Gene:59272 |
196 | 913-917 | Gene | denotes | ACE2 | Gene:59272 |
197 | 561-571 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
198 | 579-584 | Species | denotes | human | Tax:9606 |
199 | 866-876 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
200 | 542-559 | Disease | denotes | myocardial injury | MESH:D009202 |
201 | 970-981 | Disease | denotes | lung injury | MESH:D055370 |
206 | 1276-1284 | Species | denotes | patients | Tax:9606 |
207 | 1002-1014 | Disease | denotes | inflammation | MESH:D007249 |
208 | 1037-1045 | Disease | denotes | COVID-19 | MESH:C000657245 |
209 | 1306-1314 | Disease | denotes | COVID-19 | MESH:C000657245 |
215 | 1517-1523 | Chemical | denotes | oxygen | MESH:D010100 |
216 | 1419-1437 | Disease | denotes | systemic infection | MESH:D007239 |
217 | 1451-1458 | Disease | denotes | hypoxia | MESH:D000860 |
218 | 1475-1494 | Disease | denotes | respiratory illness | MESH:D012140 |
219 | 1569-1586 | Disease | denotes | myocardial injury | MESH:D009202 |
224 | 1611-1630 | Disease | denotes | coronary thrombosis | MESH:D003328 |
225 | 1641-1653 | Disease | denotes | inflammation | MESH:D007249 |
226 | 1775-1796 | Disease | denotes | myocardial infarction | MESH:D009203 |
227 | 1839-1851 | Disease | denotes | inflammation | MESH:D007249 |
229 | 2001-2009 | Disease | denotes | COVID-19 | MESH:C000657245 |
241 | 2185-2188 | Gene | denotes | esp | Gene:148713 |
242 | 2193-2201 | Species | denotes | patients | Tax:9606 |
243 | 2317-2327 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
244 | 2351-2362 | Chemical | denotes | aldosterone | MESH:D000450 |
245 | 2139-2155 | Disease | denotes | systemic illness | MESH:D002908 |
246 | 2172-2183 | Disease | denotes | arrhythmias | MESH:D001145 |
247 | 2218-2234 | Disease | denotes | cardiac disorder | MESH:D006331 |
248 | 2270-2281 | Disease | denotes | hypokalemia | MESH:D007008 |
249 | 2285-2293 | Disease | denotes | COVID-19 | MESH:C000657245 |
250 | 2375-2386 | Disease | denotes | Hypokalemia | MESH:D007008 |
251 | 2422-2438 | Disease | denotes | tachyarrhythmias | MESH:D013610 |
262 | 31-41 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
263 | 77-93 | Species | denotes | beta-coronavirus | Tax:694002 |
264 | 118-136 | Species | denotes | beta-coronaviruses | Tax:694002 |
265 | 156-161 | Species | denotes | human | Tax:9606 |
266 | 378-388 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
267 | 162-172 | Disease | denotes | infections | MESH:D007239 |
268 | 204-220 | Disease | denotes | flulike symptoms | MESH:D051271 |
269 | 293-297 | Disease | denotes | MERS | MESH:D018352 |
270 | 314-322 | Disease | denotes | COVID-19 | MESH:C000657245 |
271 | 516-524 | Disease | denotes | COVID-19 | MESH:C000657245 |
293 | 2487-2495 | Species | denotes | patients | Tax:9606 |
294 | 2720-2728 | Species | denotes | patients | Tax:9606 |
295 | 2875-2883 | Species | denotes | patients | Tax:9606 |
296 | 3761-3769 | Species | denotes | patients | Tax:9606 |
297 | 2514-2517 | Disease | denotes | CVD | MESH:D002318 |
298 | 2569-2577 | Disease | denotes | COVID-19 | MESH:C000657245 |
299 | 2797-2806 | Disease | denotes | infection | MESH:D007239 |
300 | 2889-2897 | Disease | denotes | COVID-19 | MESH:C000657245 |
301 | 2943-2951 | Disease | denotes | diabetes | MESH:D003920 |
302 | 2953-2983 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
303 | 2988-3000 | Disease | denotes | hypertension | MESH:D006973 |
304 | 3046-3054 | Disease | denotes | diabetes | MESH:D003920 |
305 | 3059-3071 | Disease | denotes | hypertension | MESH:D006973 |
306 | 3152-3182 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
307 | 3242-3250 | Disease | denotes | diabetes | MESH:D003920 |
308 | 3252-3282 | Disease | denotes | cardio-cerebrovascular disease | MESH:D002561 |
309 | 3287-3299 | Disease | denotes | hypertension | MESH:D006973 |
310 | 3618-3626 | Disease | denotes | COVID-19 | MESH:C000657245 |
311 | 3775-3787 | Disease | denotes | hypertension | MESH:D006973 |
312 | 3789-3797 | Disease | denotes | diabetes | MESH:D003920 |
313 | 3802-3805 | Disease | denotes | CVD | MESH:D002318 |
323 | 4135-4143 | Species | denotes | patients | Tax:9606 |
324 | 4386-4394 | Species | denotes | patients | Tax:9606 |
325 | 4405-4413 | Species | denotes | patients | Tax:9606 |
326 | 4581-4589 | Species | denotes | patients | Tax:9606 |
327 | 4277-4285 | Disease | denotes | diabetes | MESH:D003920 |
328 | 4307-4331 | Disease | denotes | congestive heart failure | MESH:D006333 |
329 | 4348-4367 | Disease | denotes | cardiac dysfunction | MESH:D006331 |
330 | 4414-4418 | Disease | denotes | died | MESH:D003643 |
331 | 4494-4500 | Disease | denotes | deaths | MESH:D003643 |